Ankylosing Spondylitis Clinical Trials

La Jolla : University of California, San Diego

OTIS Autoimmune Diseases in Pregnancy Project

Alpharetta : CSI Research Inc

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

Wheaton : The Center for Rheumatology and Bone Research

A randomized double blind placebo controlled dose ranging study to evaluate the efficacy and safety of IL-6Ra mAb in patients with Ankylosing Spondylitis

Brussels : Erasme University Hospital

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Diepenbeek : Limburg University Centre

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Gent : Universitair Ziekenhuis, Afdeling Rheumatologie

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Leuven : University Hospital Leuven

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Brampton : Site Reference ID/Investigator# 54758

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Brockville : Site Reference ID/Investigator# 65502

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Burlington : Site Reference ID/Investigator# 67347

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Burlington : Site Reference ID/Investigator# 54764

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Calgary : Site Reference ID/Investigator# 64274

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

View More »

Cranbrook : Site Reference ID/Investigator# 55242

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Fredericton : Site Reference ID/Investigator# 55256

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Fredericton : Site Reference ID/Investigator# 54748

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Hamilton : Site Reference ID/Investigator# 54762

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Hamilton : Site Reference ID/Investigator# 65011

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Hamilton : Site Reference ID/Investigator# 55417

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Kamloops : Site Reference ID/Investigator# 54577

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Laval : Site Reference ID/Investigator# 54576

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Mississauga : Site Reference ID/Investigator# 54581

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Mississauga : Site Reference ID/Investigator# 55401

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Mississauga : Site Reference ID/Investigator# 54750

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Montreal : Site Reference ID/Investigator# 54754

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Montreal : Site Reference ID/Investigator# 54761

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Montreal : Site Reference ID/Investigator# 63655

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Nepean : Site Reference ID/Investigator# 55410

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Ottawa : Site Reference ID/Investigator# 55296

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Outremont : Site Reference ID/Investigator# 54574

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Owen Sound : Site Reference ID/Investigator# 54583

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Penticton : Site Reference ID/Investigator# 67096

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Prince George : Site Reference ID/Investigator# 55227

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Quebec City : Site Reference ID/Investigator# 45623

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Rimouski : Site Reference ID/Investigator# 54765

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

St. Catharines : Site Reference ID/Investigator# 67282

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

St. John's : Site Reference ID/Investigator# 54757

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

St-Leonard : Site Reference ID/Investigator# 55460

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Toronto : Site Reference ID/Investigator# 55449

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Toronto : Site Reference ID/Investigator# 54751

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Toronto : Site Reference ID/Investigator# 54575

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Trois-Rivieres : Site Reference ID/Investigator# 55469

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Vancouver : Site Reference ID/Investigator# 54572

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Victoria : Site Reference ID/Investigator# 55197

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Winnipeg : Site Reference ID/Investigator# 54580

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Baotou : The First Affiliated Hospital of Baotou Medical College

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Baotou city : Baotou Central Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Beijing : Shanghai Changning Guanghua Integrative Medicine Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Changsha : The Second Xiangya Hospital of Central South University

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Chengdu : Si Chuan Huaxi Hospital/Rheumatology Department

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

View More »

Chongqing : Daping Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Fuzhou : Fujian Provincial Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Guangzhou : The First Affiliated Hospital of Guangzhou University of Chinese Medicine

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Haerbin : No. 199

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Lanzhou : Lanzhou University Second Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Nanjing : Jiangsu Province Hospital/Department of Rheumatology

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Nantong : Affiliated Hospital of Nantong University

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Shanghai : Shanghai Jiaotong University Affiliated Third People's Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Taiyuan : The Second Hospital of Shanxi Medical University

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Urumqi : Xinjiang Uygur Autonomous Region People's Hospital

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Brno : Site Reference ID/Investigator# 63774

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Kromeriz : Site Reference ID/Investigator# 63775

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Ostrava : Site Reference ID/Investigator# 63769

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Pardubice : Site Reference ID/Investigator# 63772

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Tallinn : Site Reference ID/Investigator# 71616

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Tallinn : Site Reference ID/Investigator# 71617

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Tartu : Site Reference ID/Investigator# 71618

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Helsinki : University Central Hospital, Division of Rheumatology

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Paris : Universitat R. Descartes, Hopital Cochin

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Paris : Groupe Hopitalier Cochin

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Berlin : Charite Klinikum Steglitz

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Berlin : Charite Mitte

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Berlin : Charité University Medicine Berlin, Campus Benjamin-Franklin

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

Berlin : Pfizer Investigational Site

Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

Herne : Rheumazentrum Ruhrgebiet

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

View More »

Herne : Rheumazentrum Ruhrgebiet

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

München : Ludwigs-Maximilian-Universität

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Budapest : Site Reference ID/Investigator# 49883

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Budapest : Site Reference ID/Investigator# 65206

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Budapest : Site Reference ID/Investigator# 65210

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Debrecen : Site Reference ID/Investigator# 65224

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Debrecen : Site Reference ID/Investigator# 65208

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

View More »

Eger : Site Reference ID/Investigator# 65205

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Esztergom : Site Reference ID/Investigator# 65222

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Gyor : Site Reference ID/Investigator# 65207

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Gyula : Site Reference ID/Investigator# 65223

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Heviz : Site Reference ID/Investigator# 65225

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Kecskemet : Site Reference ID/Investigator# 65203

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Kistarcsa : Site Reference ID/Investigator# 65209

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Miskolc : Site Reference ID/Investigator# 65214

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Nyiregyhaza : Site Reference ID/Investigator# 65211

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Pecs : Site Reference ID/Investigator# 65221

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Szeged : Site Reference ID/Investigator# 65204

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Szekesfehervar : Site Reference ID/Investigator# 65227

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Szombathely : Site Reference ID/Investigator# 65213

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Veszprem : Site Reference ID/Investigator# 65202

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Aichi : Site Reference ID/Investigator# 59605

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Aichi : Site Reference ID/Investigator# 68725

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Aichi : Site Reference ID/Investigator# 64970

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Aichi : Site Reference ID/Investigator# 59603

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Akita : Site Reference ID/Investigator# 54989

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

View More »

Aomori : Site Reference ID/Investigator# 51171

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Chiba : Site Reference ID/Investigator# 54720

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Chiba : Site Reference ID/Investigator# 51096

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Chiba : Site Reference ID/Investigator# 54713

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Chiba : Site Reference ID/Investigator# 51095

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Chuo : Site Reference ID/Investigator# 54991

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fuchu : Site Reference ID/Investigator# 54996

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fujieda : Site Reference ID/Investigator# 79755

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 55016

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 80934

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51114

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51163

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51168

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51124

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51164

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51165

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukuoka : Site Reference ID/Investigator# 51166

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Fukushima : Site Reference ID/Investigator# 51086

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Gifu : Site Reference ID/Investigator# 51183

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Gifu : Site Reference ID/Investigator# 54709

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Gifu : Site Reference ID/Investigator# 59585

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Gyoda : Site Reference ID/Investigator# 79756

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hamamatsu : Site Reference ID/Investigator# 54816

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hannan : Site Reference ID/Investigator# 79773

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hirakata : Site Reference ID/Investigator# 51189

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hirosaki : Site Reference ID/Investigator# 51147

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 55015

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 79754

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 51162

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 54983

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 51126

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 51127

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hiroshima : Site Reference ID/Investigator# 51155

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hokkaido : Site Reference ID/Investigator# 54987

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hokkaido : Site Reference ID/Investigator# 54715

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hokkaido : Site Reference ID/Investigator# 51122

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hyogo : Site Reference ID/Investigator# 51195

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hyogo : Site Reference ID/Investigator# 54822

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Hyogo : Site Reference ID/Investigator# 64968

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Ichinoseki : Site Reference ID/Investigator# 79758

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Ikoma : Site Reference ID/Investigator# 64934

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Isahaya : Site Reference ID/Investigator# 59607

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Iwafune : Site Reference ID/Investigator# 51088

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Izumo : Site Reference ID/Investigator# 51160

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Izunokuni : Site Reference ID/Investigator# 51190

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Izunokuni : Site Reference ID/Investigator# 51187

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Joetsu : Site Reference ID/Investigator# 84019

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Joetsu : Site Reference ID/Investigator# 84018

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kaga : Site Reference ID/Investigator# 79759

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kagoshima : Site Reference ID/Investigator# 67172

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kagoshima : Site Reference ID/Investigator# 55021

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kagoshima : Site Reference ID/Investigator# 55020

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanagawa : Site Reference ID/Investigator# 54998

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanagawa : Site Reference ID/Investigator# 54999

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanagawa : Site Reference ID/Investigator# 54712

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanazawa : Site Reference ID/Investigator# 55009

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanazawa : Site Reference ID/Investigator# 64948

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanazawa : Site Reference ID/Investigator# 64936

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kanazawa : Site Reference ID/Investigator# 55008

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kashihara : Site Reference ID/Investigator# 67171

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kashihara : Site Reference ID/Investigator# 71474

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kasugai : Site Reference ID/Investigator# 75096

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kasugai : Site Reference ID/Investigator# 75099

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kawagoe : Site Reference ID/Investigator# 51117

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kawagoe : Site Reference ID/Investigator# 51152

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kawasaki : Site Reference ID/Investigator# 51188

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kawasaki : Site Reference ID/Investigator# 75095

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kitakyushu : Site Reference ID/Investigator# 51167

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kitakyushu : Site Reference ID/Investigator# 59588

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kobe : Site Reference ID/Investigator# 59601

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kobe : Site Reference ID/Investigator# 54982

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kobe : Site Reference ID/Investigator# 54725

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kobe : Site Reference ID/Investigator# 54724

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kudamatsu : Site Reference ID/Investigator# 51158

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kumamoto : Site Reference ID/Investigator# 59586

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kurashiki : Site Reference ID/Investigator# 51170

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kurume : Site Reference ID/Investigator# 55017

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 55010

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 64933

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 51198

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 51157

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 51118

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 51119

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 51161

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 51156

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 55011

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Kyoto : Site Reference ID/Investigator# 64994

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Maebashi : Site Reference ID/Investigator# 51087

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Maebashi : Site Reference ID/Investigator# 54990

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Maizuru : Site Reference ID/Investigator# 79753

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Matsuyama : Site Reference ID/Investigator# 49884

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Minato : Site Reference ID/Investigator# 51154

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Minato : Site Reference ID/Investigator# 51151

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Miyazaki : Site Reference ID/Investigator# 67173

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagakute : Site Reference ID/Investigator# 59591

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagakute : Site Reference ID/Investigator# 51169

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagakute : Site Reference ID/Investigator# 64967

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagano : Site Reference ID/Investigator# 59608

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagano : Site Reference ID/Investigator# 51153

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagano : Site Reference ID/Investigator# 54992

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagaokakyo : Site Reference ID/Investigator# 64931

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagasaki : Site Reference ID/Investigator# 51123

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 59584

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 75097

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 54819

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 54821

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 51182

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 59600

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nagoya : Site Reference ID/Investigator# 54985

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nara : Site Reference ID/Investigator# 51186

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Niigata : Site Reference ID/Investigator# 54814

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nirasaki : Site Reference ID/Investigator# 84020

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nishinomiya : Site Reference ID/Investigator# 55004

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Nisshin : Site Reference ID/Investigator# 84194

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Obihiro : Site Reference ID/Investigator# 59604

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Obihiro : Site Reference ID/Investigator# 75094

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Oita : Site Reference ID/Investigator# 59598

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Oita : Site Reference ID/Investigator# 55019

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Okayama : Site Reference ID/Investigator# 59606

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Okayama : Site Reference ID/Investigator# 54723

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Okayama : Site Reference ID/Investigator# 55013

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Ono : Site Reference ID/Investigator# 84022

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 64935

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 55002

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 59590

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 54716

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 54984

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51185

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51191

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51173

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51125

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51149

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51150

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51113

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 54820

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 55001

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51194

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51192

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51196

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 51197

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 64932

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaka : Site Reference ID/Investigator# 59602

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Osaki : Site Reference ID/Investigator# 51083

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Otsu : Site Reference ID/Investigator# 64938

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Otsu : Site Reference ID/Investigator# 55012

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Saga : Site Reference ID/Investigator# 55018

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sagamihara : Site Reference ID/Investigator# 54818

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Saitama : Site Reference ID/Investigator# 51120

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Saitama : Site Reference ID/Investigator# 54997

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Saitama : Site Reference ID/Investigator# 54986

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sakai : Site Reference ID/Investigator# 84021

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sapporo : Site Reference ID/Investigator# 51084

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sapporo : Site Reference ID/Investigator# 51085

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sapporo : Site Reference ID/Investigator# 59597

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sapporo : Site Reference ID/Investigator# 54988

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sayama : Site Reference ID/Investigator# 51097

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sendai : Site Reference ID/Investigator# 51116

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Sendai : Site Reference ID/Investigator# 51148

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Shimane : Site Reference ID/Investigator# 59593

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Shinjuku-ku : Site Reference ID/Investigator# 54994

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Takamatsu : Site Reference ID/Investigator# 54710

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Takatsuki : Site Reference ID/Investigator# 55003

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Takatsuki : Site Reference ID/Investigator# 51193

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tenri : Site Reference ID/Investigator# 54726

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tochigi : Site Reference ID/Investigator# 59592

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 64937

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 68726

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54711

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54717

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54718

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54721

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54722

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54995

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54993

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 54815

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51089

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51092

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51094

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51146

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51172

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51174

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51129

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51121

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51115

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51090

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51091

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51093

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 51082

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 59587

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 79757

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tokyo : Site Reference ID/Investigator# 71476

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tomakomai : Site Reference ID/Investigator# 59596

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 59599

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 59589

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 55006

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 55007

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 51128

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 55005

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyama : Site Reference ID/Investigator# 64996

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyoake : Site Reference ID/Investigator# 64995

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Toyohashi : Site Reference ID/Investigator# 80918

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tsukuba : Site Reference ID/Investigator# 59594

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Tsuyama : Site Reference ID/Investigator# 71475

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Urayasu : Site Reference ID/Investigator# 54714

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Wakayama : Site Reference ID/Investigator# 54817

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yamaguchi : Site Reference ID/Investigator# 51159

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yamaguchi : Site Reference ID/Investigator# 64969

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yamaguchi : Site Reference ID/Investigator# 54823

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yokohama : Site Reference ID/Investigator# 80933

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yokohama : Site Reference ID/Investigator# 75098

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yokohama : Site Reference ID/Investigator# 59595

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yokohama : Site Reference ID/Investigator# 55000

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Yonago : Site Reference ID/Investigator# 55014

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Seoul : Hanyang University Hospital for rheumatic disease

The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection

Amsterdam : Academic Ziekenhuis

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Haarlem : Merck Sharp & Dohme BV

The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)

Maastricht : University Hospital Maastricht

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Lillehammer : Lillehammer Hospital for Rheumatic Diseases

Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment

Brasov : Site Reference ID/Investigator# 66393

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Brasov : Site Reference ID/Investigator# 66394

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 69661

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 66366

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 66378

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

View More »

Bucharest : Site Reference ID/Investigator# 66364

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 66365

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 66376

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 66377

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Bucharest : Site Reference ID/Investigator# 90253

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Constanta : Site Reference ID/Investigator# 66398

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Craiova : Site Reference ID/Investigator# 66389

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Craiova : Site Reference ID/Investigator# 66390

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Craiova : Site Reference ID/Investigator# 69390

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Craiova : Site Reference ID/Investigator# 88633

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Deva : Site Reference ID/Investigator# 66402

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Deva : Site Reference ID/Investigator# 66403

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Iasi : Site Reference ID/Investigator# 66385

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Iasi : Site Reference ID/Investigator# 66386

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Iasi : Site Reference ID/Investigator# 66387

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Iasi : Site Reference ID/Investigator# 66384

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Ploiesti : Site Reference ID/Investigator# 66405

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Sibiu : Site Reference ID/Investigator# 66400

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Sibiu : Site Reference ID/Investigator# 66397

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Targu-Mures : Site Reference ID/Investigator# 66391

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Timisoara : Site Reference ID/Investigator# 66383

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Moscow : Site Reference ID/Investigator# 94619 Updated

Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

Tula : Site Reference ID/Investigator# 94629 Updated

Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

Banska Bystrica : Site Reference ID/Investigator# 64342

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Kosice : Site Reference ID/Investigator# 64343

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Piestany : Site Reference ID/Investigator# 65732

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Piestany : Site Reference ID/Investigator# 65733

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Kharkov : Site Reference ID/Investigator# 70696

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Cambridge : University of Cambridge/ Clin Med

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Leeds : University of Leeds

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

London : Novartis Investigative Site

Efficacy at 16 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Ankylosing Spondylitis (AS)